Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
Conditions
- Solid Tumor
- Advanced Solid Tumor
- Metastatic Solid Tumor
Interventions
- DRUG: BSI-082
- OTHER: Trastuzumab deruxtecan
Sponsor
Lei Zheng
Collaborators